PIM-447 dihydrochloride is primarily used in research and development, particularly in the field of oncology. It functions as a potent inhibitor of PIM kinases, which are enzymes involved in cell survival, proliferation, and differentiation. By targeting these kinases, PIM-447 dihydrochloride is studied for its potential to inhibit the growth of cancer cells, especially in hematologic malignancies such as leukemia and lymphoma. Researchers explore its efficacy in preclinical models to understand its role in inducing apoptosis and reducing tumor progression. Additionally, it is being investigated in combination therapies to enhance the effectiveness of other anticancer agents. Its application extends to understanding molecular pathways in cancer biology, aiding in the development of targeted therapies.